Compare · DFTX vs USNA
DFTX vs USNA
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and USANA Health Sciences Inc. (USNA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and USNA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $4.83B, about 12.0x USNA ($402.9M).
- DFTX has been more active in the news (29 items in the past 4 weeks vs 2 for USNA).
- DFTX has more recent analyst coverage (5 ratings vs 3 for USNA).
- Company
- Definium Therapeutics Inc.
- USANA Health Sciences Inc.
- Price
- -
- -
- Market cap
- $4.83B
- $402.9M
- 1M return
- +83.23%
- -
- 1Y return
- +398.31%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 29
- 2
- Recent ratings
- 5
- 3
USANA Health Sciences Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Latest DFTX
- Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
- Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
- New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
- Definium Therapeutics Announces New Employee Inducement Grants
- Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
- Chief Legal Officer Sullivan Mark sold $585,750 worth of shares (13,008 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 320,571 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Karlin Daniel sold $451,876 worth of shares (10,035 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 503,282 units (SEC Form 4) (withholding obligation)
- Chief Financial Officer Roberts Brandi sold $135,675 worth of shares (3,013 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 209,487 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Barrow Robert sold $1,315,236 worth of shares (29,208 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,098,246 units (SEC Form 4) to satisfy withholding obligation
- Chief Commercial Officer Wiley Matthew T. sold $129,101 worth of shares (2,867 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 174,633 units (SEC Form 4) (withholding obligation)
Latest USNA
- USANA Schedules Second Quarter 2026 Earnings Release and Conference Call
- Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence
- CHIEF COMMERCIAL OFFICER Neidig Brent sold $97,304 worth of shares (5,002 units at $19.45), closing all direct ownership in the company (SEC Form 4)
- CHIEF COMMERCIAL OFFICER Neidig Brent sold $50,465 worth of shares (2,511 units at $20.10), decreasing direct ownership by 33% to 5,002 units (SEC Form 4)
- USANA Celebrates 10 Years of Making the World a Better Place During World Service Week
- SEC Form 11-K filed by USANA Health Sciences Inc.
- CHIEF PEOPLE OFFICER Jones Paul A. sold $102,878 worth of shares (5,561 units at $18.50), closing all direct ownership in the company (SEC Form 4)
- USANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products
- USANA Earns Dual Best of State Honors for Product Innovation and Development
- Director Fleming John Turman sold $43,928 worth of shares (2,450 units at $17.93), decreasing direct ownership by 37% to 4,230 units (SEC Form 4)